Post job

Infermedica CEO and executives

Executive Summary. Based on our data team's research, Piotr Orzechowski is the Infermedica's CEO. Infermedica has 125 employees, of which 16 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Infermedica executive team is 38% female and 63% male.
  • 61% of the management team is White.
  • 11% of Infermedica management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at Infermedica?
Share your experience

Rate Infermedica's leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Piotr Orzechowski

CEO

Piotr Orzechowski's LinkedIn

Piotr is a co-founder and CEO of Infermedica which is a healthcare Artificial Intelligence and machine learning company based in Poland and United States. He is an energetic IT entrepreneur with strong technical background with key interests in digital health and mobile technologies. Prior to funding Infermedica he was engaged in numerous startup ventures including a successful Polish Dropbox-clone, mobile games studio and a software house specializing on expert systems.

Irving Loh M.D. Facc Faha Fccp Facp

Chief Medical Officer

Irving Loh M.D. Facc Faha Fccp Facp's LinkedIn

Board certified internist & subspecialty board certified cardiac specialist with emphasis on preventive cardiology. Founder Ventura Heart Institute (education, research & preventive cardiovascular programs), former Asst Prof Med/UCLA School of Medicine & former Asst Clin Prof Med/UC Irvine. Adjunct Lecturer, Stanford University, Department of Medicine. Undergraduate: UC Berkeley; MD & internal medicine: UC San Francisco. Initial lipid research: National Heart, Lung & Blood Institute at National Institutes of Health (NIH) in both intramural (Molecular Diseases/Lipid Metabolism Branch) & extramural (Cardiac Diseases Branch; Division of Heart & Vascular Diseases) divisions. Faculty in both Departments of Cardiology & Cardiac Surgery at Cedars-Sinai. Chair hospital IRB (x18y), founded BioEthics Committee, directed echocardiography lab. Principal investigator |160 cardiovascular clinical trials (dyslipidemia including PCSK9i's & CETPi's, also heart failure & hypertension). Member of Doximity Medical Advisory Board, Advisor to Global Health Impact Fund, UBERDoc, Kencor Health, Tiatros, and MOREHealth. In 1987, wrote his first EHR with integrated quality of care metrics. Presented at RAND, USC School of Business, UCLA Anderson School of Business, Mayo Clinic in Rochester MN, & both UC Berkeley's Center for Information Technology Research in the Interest of Society & School of Public Health & Harvard School of Public Health. Presented at TEDx on how medical advances are validated (see link). Chair, ACC FH Work Group subcommittee on Clinical Implementation. Current activities include Chief Medical Advisor/ConfideoLabs/DoctorVirtualis for virtual reality in healthcare, lead contributor to SERMO's Cardiology Hub, Director Cardiovascular Services for MORE Health, CMO & Co-founder of Infermedica (AI/machine learning into clinical decision support). Chair, Technology & Innovation Committee, & Member, Board of Directors, California Chapter American College of Cardiology/Outstanding Achievement Award 2019. Member, International Telecommunication Union Focus Group AI for Health (AI for symptom assessment & AI for clinical evaluation)/WHO/UN.

Roberto Sicconi

Co-Founder & CSO

Roberto Sicconi's LinkedIn

Lifetime goal: “reinvent” human-machine interfaces by creative integration of silicon technology, signal processing, communication protocols, distributed-computing, smart dialog management.Co-Founder of dreyev LLCDreyev is a real-time driver attention monitoring, coaching and management system to prevent distracted and drowsy driving. Safer driving behavior prevents crashes and enables fairer and more accurate risk-based insurance policy pricing. Loss prevention, risk mitigation, driving coaching bot.Co-Founder of TeleLingo LLCLive interactive, remote one-on-one tutoring of foreign languages, English as a Second Language, pronunciation and negotiation skills refinement for business professionals). Smart videoconferencing, blended learning, tools for cadenced practice and automated progress monitoring.Co-Founder and CSO at Infermedica Inc., to empower Healthcare Companies with Artificial Intelligence and Smart Heath Advisory Bots.Board Advisor at SoundBite Inc.SoundBite Inc. is aiming to end social isolation in the mobile world by re-establishing the human connection with your friends and family.Background- Extensive knowledge of Computer Architectures, Mobile and Interactive Entertainment devices for access to information anytime, anywhere, via human-friendly interfaces.- Leadership role in Automotive sector, directing key projects with top OEMs and Tier-1s to advance state of the art of Driver Safety, Navigation, Infotainment, Connected-Car Telematics and Location-based Services. - Extensive experience in launching and managing new business initiatives around IBM Watson Question-Answering Technology to address multi-$B level opportunities in Healthcare and Automated Customer Support. - Over two decades of experience in establishing multi-year multi-million customer engagements across Europe/Asia/ US, leveraging multiple IBM and Customer R&D organizations.

Tomasz Domino

Chief Operating Officer

Tomasz Domino's LinkedIn

Tomasz Domino (多米诺) is a Chief Operating Officer at Infermedica and is based in Wroclaw Lower Silesian District Poland. He has worked as Business Analyst at Deloitte, Auditor at KPMG, and Member of the Supervisory Board at Infermedica. Tomasz attended Tianjin University of Technology between 2013 and 2014, 华南理工大学 between 2014 and 2015, and Uniwersytet Ekonomiczny we Wrocławiu between 2005 and 2010.

MacIej Ławrowski

Chief Financial Officer

MacIej Ławrowski's LinkedIn

Maciej Ławrowski is a Chief Financial Officer at Infermedica and is based in Wrocław Woj., Dolnośląskie Voivodship, Poland. He has worked as Senior Associate - Valuation & Financial Modeling at Deloitte, M&A Senior Analyst at ORLEN UPSTREAM SP Z O O, and M&A Manager at AmRest.

Paweł Iwaszko

CTO

Paweł Iwaszko's LinkedIn

Paweł Iwaszko is a CTO at Infermedica and is based in Wroclaw, Dolnośląskie Voivodship, Poland. He has worked as Software Engineer at Nokia and Continuous Integration Engineer at Nokia. Paweł studied at Politechnika Wrocławska between 2005 and 2010.

Amy Window

Head of Sales

Amy Window's LinkedIn

Łukasz Przywarty

VP of Design

Łukasz Przywarty's LinkedIn

Alex Long

VP of Sales

Alex Long's LinkedIn

Alicja Heyduk

VP of Customer Success & Implementation

Alicja Heyduk's LinkedIn

Do you work at Infermedica?

Does leadership effectively guide Infermedica toward its goals?

Infermedica jobs

Infermedica founders

Name & TitleBio
Piotr Orzechowski

CEO

Piotr Orzechowski's LinkedIn

Piotr is a co-founder and CEO of Infermedica which is a healthcare Artificial Intelligence and machine learning company based in Poland and United States. He is an energetic IT entrepreneur with strong technical background with key interests in digital health and mobile technologies. Prior to funding Infermedica he was engaged in numerous startup ventures including a successful Polish Dropbox-clone, mobile games studio and a software house specializing on expert systems.

Irving Loh M.D. Facc Faha Fccp Facp

Chief Medical Officer

Irving Loh M.D. Facc Faha Fccp Facp's LinkedIn

Board certified internist & subspecialty board certified cardiac specialist with emphasis on preventive cardiology. Founder Ventura Heart Institute (education, research & preventive cardiovascular programs), former Asst Prof Med/UCLA School of Medicine & former Asst Clin Prof Med/UC Irvine. Adjunct Lecturer, Stanford University, Department of Medicine. Undergraduate: UC Berkeley; MD & internal medicine: UC San Francisco. Initial lipid research: National Heart, Lung & Blood Institute at National Institutes of Health (NIH) in both intramural (Molecular Diseases/Lipid Metabolism Branch) & extramural (Cardiac Diseases Branch; Division of Heart & Vascular Diseases) divisions. Faculty in both Departments of Cardiology & Cardiac Surgery at Cedars-Sinai. Chair hospital IRB (x18y), founded BioEthics Committee, directed echocardiography lab. Principal investigator |160 cardiovascular clinical trials (dyslipidemia including PCSK9i's & CETPi's, also heart failure & hypertension). Member of Doximity Medical Advisory Board, Advisor to Global Health Impact Fund, UBERDoc, Kencor Health, Tiatros, and MOREHealth. In 1987, wrote his first EHR with integrated quality of care metrics. Presented at RAND, USC School of Business, UCLA Anderson School of Business, Mayo Clinic in Rochester MN, & both UC Berkeley's Center for Information Technology Research in the Interest of Society & School of Public Health & Harvard School of Public Health. Presented at TEDx on how medical advances are validated (see link). Chair, ACC FH Work Group subcommittee on Clinical Implementation. Current activities include Chief Medical Advisor/ConfideoLabs/DoctorVirtualis for virtual reality in healthcare, lead contributor to SERMO's Cardiology Hub, Director Cardiovascular Services for MORE Health, CMO & Co-founder of Infermedica (AI/machine learning into clinical decision support). Chair, Technology & Innovation Committee, & Member, Board of Directors, California Chapter American College of Cardiology/Outstanding Achievement Award 2019. Member, International Telecommunication Union Focus Group AI for Health (AI for symptom assessment & AI for clinical evaluation)/WHO/UN.

Roberto Sicconi

Co-Founder & CSO

Roberto Sicconi's LinkedIn

Lifetime goal: “reinvent” human-machine interfaces by creative integration of silicon technology, signal processing, communication protocols, distributed-computing, smart dialog management.Co-Founder of dreyev LLCDreyev is a real-time driver attention monitoring, coaching and management system to prevent distracted and drowsy driving. Safer driving behavior prevents crashes and enables fairer and more accurate risk-based insurance policy pricing. Loss prevention, risk mitigation, driving coaching bot.Co-Founder of TeleLingo LLCLive interactive, remote one-on-one tutoring of foreign languages, English as a Second Language, pronunciation and negotiation skills refinement for business professionals). Smart videoconferencing, blended learning, tools for cadenced practice and automated progress monitoring.Co-Founder and CSO at Infermedica Inc., to empower Healthcare Companies with Artificial Intelligence and Smart Heath Advisory Bots.Board Advisor at SoundBite Inc.SoundBite Inc. is aiming to end social isolation in the mobile world by re-establishing the human connection with your friends and family.Background- Extensive knowledge of Computer Architectures, Mobile and Interactive Entertainment devices for access to information anytime, anywhere, via human-friendly interfaces.- Leadership role in Automotive sector, directing key projects with top OEMs and Tier-1s to advance state of the art of Driver Safety, Navigation, Infotainment, Connected-Car Telematics and Location-based Services. - Extensive experience in launching and managing new business initiatives around IBM Watson Question-Answering Technology to address multi-$B level opportunities in Healthcare and Automated Customer Support. - Over two decades of experience in establishing multi-year multi-million customer engagements across Europe/Asia/ US, leveraging multiple IBM and Customer R&D organizations.

Infermedica board members

Name & TitleBio
Michal Rokosz

Board Member

Anna Grigoryeva

Board Member

Margus Uudam

Board Member

Infermedica executives FAQs

Zippia gives an in-depth look into the details of Infermedica, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Infermedica. The employee data is based on information from people who have self-reported their past or current employments at Infermedica. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Infermedica. The data presented on this page does not represent the view of Infermedica and its employees or that of Zippia.

Infermedica may also be known as or be related to Infermedica, Infermedica Inc. and Infermedica Sp. z o.o.